CORC  > 中国医学科学院 北京协和医学院
Efficacy and safety of saxagliptin monotherapy or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24-week, post-marketing SUNSHINE study
Gu, Weiqiong; Liang, Li.; Wang, Shengxiang; Wang, Yunzhi; Wu, Yanxiang; Tian, Jian; Yang, Gangyi; Piao, Chunli; Li, Yuzhong; Yin, Jianmei
2016
卷号8期号:6页码:809-815
关键词efficacy safety saxagliptin type 2 diabetes mellitus
ISSN号1753-0393
DOI10.1111/1753-0407.12360
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6376074
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Gu, Weiqiong,Liang, Li.,Wang, Shengxiang,et al. Efficacy and safety of saxagliptin monotherapy or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24-week, post-marketing SUNSHINE study[J],2016,8(6):809-815.
APA Gu, Weiqiong.,Liang, Li..,Wang, Shengxiang.,Wang, Yunzhi.,Wu, Yanxiang.,...&Wang, Weiqing.(2016).Efficacy and safety of saxagliptin monotherapy or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24-week, post-marketing SUNSHINE study.,8(6),809-815.
MLA Gu, Weiqiong,et al."Efficacy and safety of saxagliptin monotherapy or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24-week, post-marketing SUNSHINE study".8.6(2016):809-815.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace